Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 703.81 Million SAR | 18.5% |
| 2022 | 593.92 Million SAR | 25.12% |
| 2021 | 474.69 Million SAR | -7.52% |
| 2020 | 513.29 Million SAR | 22.38% |
| 2019 | 419.43 Million SAR | -4.3% |
| 2018 | 438.29 Million SAR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 194.41 Million SAR | -10.9% |
| 2024 Q1 | 249.4 Million SAR | 109.76% |
| 2024 Q2 | 218.18 Million SAR | -12.52% |
| 2023 Q4 | 118.9 Million SAR | -36.49% |
| 2023 FY | 703.8 Million SAR | 18.5% |
| 2023 Q3 | 187.22 Million SAR | -5.49% |
| 2023 Q2 | 198.09 Million SAR | -0.76% |
| 2023 Q1 | 199.6 Million SAR | 59.16% |
| 2022 Q2 | 153.06 Million SAR | -6.85% |
| 2022 Q1 | 164.32 Million SAR | 20.57% |
| 2022 FY | 593.92 Million SAR | 25.12% |
| 2022 Q4 | 125.41 Million SAR | -17.01% |
| 2022 Q3 | 151.12 Million SAR | -1.27% |
| 2021 FY | 474.69 Million SAR | -7.52% |
| 2021 Q4 | 136.28 Million SAR | 0.0% |
| 2021 Q3 | 136.28 Million SAR | 9.25% |
| 2021 Q2 | 124.75 Million SAR | 23.44% |
| 2021 Q1 | 101.05 Million SAR | 0.0% |
| 2020 FY | 513.29 Million SAR | 22.38% |
| 2019 FY | 419.43 Million SAR | -4.3% |
| 2018 FY | 438.29 Million SAR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 708.08 Million SAR | 0.602% |